Literature DB >> 9548256

Human CD14 mediates recognition and phagocytosis of apoptotic cells.

A Devitt1, O D Moffatt, C Raykundalia, J D Capra, D L Simmons, C D Gregory.   

Abstract

Cells undergoing programmed cell death (apoptosis) are cleared rapidly in vivo by phagocytes without inducing inflammation. Here we show that the glycosylphosphatidylinositol-linked plasma-membrane glycoprotein CD14 on the surface of human macrophages is important for the recognition and clearance of apoptotic cells. CD14 can also act as a receptor that binds bacterial lipopolysaccharide (LPS), triggering inflammatory responses. Overstimulation of CD14 by LPS can cause the often fatal toxic-shock syndrome. Here we show that apoptotic cells interact with CD14, triggering phagocytosis of the apoptotic cells. This interaction depends on a region of CD14 that is identical to, or at least closely associated with, a region known to bind LPS. However, apoptotic cells, unlike LPS, do not provoke the release of pro-inflammatory cytokines from macrophages. These results indicate that clearance of apoptotic cells is mediated by a receptor whose interactions with 'non-self' components (LPS) and 'self' components (apoptotic cells) produce distinct macrophage responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548256     DOI: 10.1038/33169

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  133 in total

Review 1.  Vascular smooth muscle cell apoptosis in atherosclerosis.

Authors:  J J Boyle
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

Review 2.  Clearance: the last and often forgotten stage of apoptosis.

Authors:  V A Fadok
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

3.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

Authors:  Mai-Lan N Huynh; Valerie A Fadok; Peter M Henson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 4.  Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

Authors:  S M Moghimi; A C Hunter
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

5.  Recognition and phagocytosis of apoptotic T cells by resident murine tissue macrophages require multiple signal transduction events.

Authors:  Bin Hu; Antonello Punturieri; Jill Todt; Joanne Sonstein; Timothy Polak; Jeffrey L Curtis
Journal:  J Leukoc Biol       Date:  2002-05       Impact factor: 4.962

Review 6.  Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement.

Authors:  S P Hart; J R Smith; I Dransfield
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 7.  The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?

Authors:  Christopher D Gregory; Andrew Devitt
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

8.  CD14 triggers autoimmune Type 1 diabetes in the NOD mouse.

Authors:  N Klöting; I Klöting; R S Jack
Journal:  Diabetologia       Date:  2003-11-12       Impact factor: 10.122

9.  ß-adrenergic stimulation increases macrophage CD14 expression and E. coli phagocytosis through PKA signaling mechanisms.

Authors:  Kuzhali Muthu; Li-K He; Andrea Szilagyi; Patrick Strotmon; Richard L Gamelli; Ravi Shankar
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

10.  Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance.

Authors:  John K Hermann; Madhumitha Ravikumar; Andrew J Shoffstall; Evon S Ereifej; Kyle M Kovach; Jeremy Chang; Arielle Soffer; Chun Wong; Vishnupriya Srivastava; Patrick Smith; Grace Protasiewicz; Jingle Jiang; Stephen M Selkirk; Robert H Miller; Steven Sidik; Nicholas P Ziats; Dawn M Taylor; Jeffrey R Capadona
Journal:  J Neural Eng       Date:  2018-04       Impact factor: 5.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.